Autoimmune hepatitis is a chronic liver disease characterized by inflammation of the liver tissue due to the body's immune system mistakenly attacking healthy liver cells. It can lead to progressive liver damage, cirrhosis, and liver failure if left untreated. Treatment typically involves immunosuppressive medications to suppress the immune system's response and reduce inflammation, along with close monitoring to manage symptoms and prevent complications.
Patients are the experts in their condition and advocacy groups provide a platform for patient voices. Working directly with these communities is the key to pushing research forward in an inclusive way.
Autoimmune Hepatitis (AIH) is a rare & complex liver disorder that affects individuals worldwide. Navigating life with AIH can be challenging, but Leapcure is dedicated to providing a platform equipped with resources, including testimonials and connections to advocacy groups, aimed at empowering both patients and advocates within the AIH community.
Read more...
We’ve committed to having 500,000 conversations in the next three years, to equip ourselves and our Pharma partners with the insights needed to increase predictability.
Read more...
The ever-growing investment in advocacy doesn’t appear to be slowing down, and research is certainly seeing the benefits. Which at the end of the day, means better patient care and more options for patients.
Read more...
We’re ready to keep forming links between our Advocacy friends and Pharma partners, so these fruitful relationships continue to evolve beyond the study-to-study view.
Read more...